Sessioni Poster


Drugs, stem cells and cell therapy

Thursday, October 26th / 19.00-21.00
132bFGF/FGFR1 SIGNALING IS THE MAIN TARGET OF THE CYTOTOXIC ACTIVITY OF SORAFENIB IN HUMAN PLEURAL MESOTHELIOMA TUMOR-INITIATING CELLS
Barbieri F., Pattarozzi A., Delodi G., Favoni RE., Wurth R., Daga A., Florio T.
155GLUCOCORTICOID-INDUCED LEUCINE ZIPPER (GILZ) REGULATES HEMATOPOIETIC STEM AND PROGENITORS CELL FUNCTION
Bruscoli S., Flamini S., Frammartino T., Donnini S., Gagliardi A., Adamo F., Bereshchenko O., Riccardi C.
258THE EFFECT OF ARA-C TREATMENT ON HEMATOPOIETIC STEM CELL EXPANSION AND LEUKEMOGENESIS IN A MOUSE MODEL OF CEBPA MUTANT ACUTE MYELOID LEUKEMIA
Flamini S., Bereshchenko O., Cimino M., Culicchi F., Bruscoli S., Riccardi C.
308Angiotensin-II activates p-38 and the growth of human satellite cells: a role for type 1 receptor activation in self-renewal?
Laurino A., Blescia S., Mugelli A., Cerbai E., Sartiani L., Raimondi L.
340Measurement of deferasirox plasma concentrations in pediatric hematopoietic stem cell transplantation patients with iron overload. Is it useful the application in clinical practice?
Mattioli F., Fucile C., Marini V., Gregori M., Simeone R., Sonzogni A., Maximova N., Martelli A.
425Enhancement of cardiac differentiation of mouse pluripotent stem cells by _3 adrenoceptor stimulation
Spinelli V., Sartiani L., Laurino A., Raimondi L., Calvani M., Filippi L., Mugelli A., Cerbai E.
426Studying the mechanism of rat adipose derived stem cells in counteracting oxaliplatin-induced neuropathy: similarities with bevacizumab
Tenci B., Di cesare mannelli L., Micheli L., Maresca M., Lucarini E., Trallori E., Awada K., Vona A., Failli P., Ghelardini C.
450VEGF INVOLVEMENT IN THE OXALIPLATIN-INDUCED NEUROPATHY IN RATS: EFFECT OF ADIPOSE STEM CELLS.
Vona A., Tenci B., Di cesare mannelli L., Micheli L., Lucarini E., Ghelardini C., Failli P.